4//SEC Filing
Bhavnagri Veer 4
Accession 0001593968-23-000317
CIK 0001737287other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:10 PM ET
Size
4.5 KB
Accession
0001593968-23-000317
Insider Transaction Report
Form 4
Bhavnagri Veer
General Counsel
Transactions
- Sale
Common Stock
2023-02-13$6.85/sh−3,000$20,550→ 577,677 total
Footnotes (1)
- [F1]1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001808980
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:10 PM ET
- Size
- 4.5 KB